Delayed-start analysis for demonstrating disease modification of solanezumab

Frank J. Wolters; M. Arfan Ikram

doi:10.1016/j.trci.2015.09.002

Delayed-start analysis for demonstrating disease modification of solanezumab

Frank J. Wolters
, M. Arfan Ikram^*

^*Corresponding author for this work

Epidemiology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

13 Downloads (Pure)

Original language	English
Pages (from-to)	196-197
Number of pages	2
Journal	Alzheimer's and Dementia: Translational Research and Clinical Interventions
Volume	1
Issue number	3
DOIs	https://doi.org/10.1016/j.trci.2015.09.002
Publication status	Published - Nov 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.trci.2015.09.002Licence: CC BY-NC-ND

Delayed-start analysis for demonstrating disease modification of solanezumabFinal published version, 165 KBLicence: CC BY-NC-ND

Cite this

@article{8a32ea7dea36471892bc3324e98ac316,

title = "Delayed-start analysis for demonstrating disease modification of solanezumab",

author = "Wolters, \{Frank J.\} and Ikram, \{M. Arfan\}",

year = "2015",

month = nov,

doi = "10.1016/j.trci.2015.09.002",

language = "English",

volume = "1",

pages = "196--197",

journal = "Alzheimer's and Dementia: Translational Research and Clinical Interventions",

issn = "2352-8737",

publisher = "John Wiley \& Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Delayed-start analysis for demonstrating disease modification of solanezumab

AU - Wolters, Frank J.

AU - Ikram, M. Arfan

PY - 2015/11

Y1 - 2015/11

UR - https://www.scopus.com/pages/publications/84951054018

U2 - 10.1016/j.trci.2015.09.002

DO - 10.1016/j.trci.2015.09.002

M3 - Comment/Letter to the editor

C2 - 29854938

AN - SCOPUS:84951054018

SN - 2352-8737

VL - 1

SP - 196

EP - 197

JO - Alzheimer's and Dementia: Translational Research and Clinical Interventions

JF - Alzheimer's and Dementia: Translational Research and Clinical Interventions

IS - 3

ER -

Delayed-start analysis for demonstrating disease modification of solanezumab

UN SDGs

Access to Document

Other files and links

Cite this